|
TOMM70A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.60880000011599E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84688999999016E-05 |
| Normal-vs-Stage2 |
1.761650E-01 |
| Normal-vs-Stage3 |
2.24770000389896E-08 |
| Normal-vs-Stage4 |
1.52653999999641E-05 |
| Stage1-vs-Stage2 |
1.225820E-02 |
| Stage1-vs-Stage3 |
5.088200E-02 |
| Stage1-vs-Stage4 |
2.228400E-01 |
| Stage2-vs-Stage3 |
1.434590E-04 |
| Stage2-vs-Stage4 |
2.236100E-03 |
| Stage3-vs-Stage4 |
8.979000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.66959999556593E-08 |
| Normal-vs-AfricanAmerican |
1.610430E-02 |
| Normal-vs-Asian |
2.765100E-04 |
| Caucasian-vs-AfricanAmerican |
2.905800E-01 |
| Caucasian-vs-Asian |
4.521800E-01 |
| AfricanAmerican-vs-Asian |
6.204800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.63470000000321E-05 |
| Normal-vs-Female |
9.75319999985125E-07 |
| Male-vs-Female |
9.503600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.243050E-04 |
| Normal-vs-Age(41-60Yrs) |
6.67300000034565E-07 |
| Normal-vs-Age(61-80Yrs) |
2.607000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.222400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.399800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.683000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.646800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.223800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.701800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.922400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.348360E-02 |
| Classical-VS-Follicular |
4.824300E-02 |
| Classical-VS-Other |
7.678000E-01 |
| Classical-VS-Normal |
1.08279999999628E-06 |
| Tall-VS-Follicular |
6.241000E-04 |
| Tall-VS-Other |
6.459200E-01 |
| Tall-VS-Normal |
1.44779999988742E-07 |
| Follicular-VS-Other |
3.955800E-01 |
| Follicular-VS-Normal |
2.276100E-02 |
| Other-VS-Normal |
5.514400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10920000000003E-05 |
| Normal-vs-N1 |
4.95090000107723E-08 |
| N0-vs-N1 |
2.022400E-02 |
|
|
